A Widal test showing S. Typhi O antigen titer of 1:160 is NOT sufficient to confirm enteric fever and should not be used as the sole diagnostic criterion.
Why the Widal Test is Unreliable
The most authoritative guideline explicitly states that serologic tests, including the Widal test, are not recommended to establish an etiology of enteric fever 1. This recommendation from the 2017 IDSA guidelines carries a "strong, low" rating, reflecting consistent expert consensus despite limited high-quality evidence.
The UK fever guidelines similarly emphasize that "the serological Widal test lacks sensitivity and specificity and is not recommended" for diagnosing enteric fever in returned travelers 2.
The Evidence Against Using Widal at 1:160
While older research studies from the 1980s-1990s suggested that a 1:160 titer had reasonable performance characteristics:
- Sensitivity ranged from 61-77% in culture-proven typhoid 3, 4, 5, 6
- Specificity was reported at 89-97% 3, 4, 5
However, these studies reveal critical problems:
- False positives are common: 6-11% of patients with other febrile illnesses test positive at 1:160 7
- In endemic areas like Bangladesh, healthy individuals can have baseline titers up to 1:80 8
- The test detects antibodies from previous exposure, vaccination, or cross-reactive infections—not necessarily active disease
- More false positives occur than false negatives 6
What You Should Do Instead
Blood culture remains the definitive diagnostic test and should be obtained when enteric fever is suspected 2, 9. Consider enteric fever when:
- Febrile patient with travel history to endemic areas (South/Southeast Asia, Central/South America, Africa) 9
- Consumed food prepared by someone with recent endemic exposure 9
- Laboratory exposure to S. Typhi 9
Key diagnostic approach:
- Obtain blood cultures (highest yield within first week of symptoms) 2
- Stool and urine cultures become positive after the first week 2
- Bone marrow culture has higher sensitivity than blood culture if available 2
- Blood culture sensitivity is 40-80%; combining multiple culture sites improves detection 2
Critical Clinical Pitfall
If clinical suspicion is high and the patient is unstable, start empirical treatment without waiting for culture results 2. In patients from Asia, use intravenous ceftriaxone as first-line due to widespread fluoroquinolone resistance (>70% of UK isolates) 2. All recent isolates remain sensitive to ceftriaxone 2.
Bottom Line
A Widal titer of 1:160 cannot confirm typhoid fever. It may support the diagnosis in the right clinical context (fever, appropriate travel history, compatible symptoms), but diagnosis requires either positive blood/stool/urine culture or strong clinical suspicion with epidemiologic risk factors 9, 10. The clinical picture and culture results are decisive—not serology 6.